Physician profile
Thomas James Hill
NPI 1992799357
$11,749.28
in general payments reported to CMS, 2019-2025
21 companies · $772 in 2025
The $772 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,950 · 2020: $343 · 2021: $115 · 2022: $475 · 2023: $579 · 2024: $515 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,866.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,393.91 | 2019-2024 | |
| Abiomed | $1,190.28 | 2019-2025 | Impella |
| Pfizer INC. | $504.72 | 2019-2025 | |
| Boston Scientific Corporation | $351.20 | 2019-2025 | Avvigo Guidance System |
| Abbott Laboratories | $191.17 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint |
| E.R. Squibb & Sons, L.L.C. | $176.61 | 2023 | Camzyos |
| Medtronic, INC. | $174.74 | 2021-2025 | Linq II, Concertotm |
| Atricure, INC. | $172.69 | 2022 | |
| Heartflow, INC. | $124.65 | 2023 | Ffrct |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.10 | 2020 | |
| Impulse Dynamics (USA) INC. | $79.49 | 2024-2025 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $59.33 | 2019-2023 | Uptravi, Opsumit |
| Edwards Lifesciences Corporation | $41.42 | 2020-2022 | |
| United Therapeutics Corporation | $35.00 | 2025 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $31.37 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $28.52 | 2020-2022 | |
| Medtronic Vascular, INC. | $20.02 | 2020 | |
| Cordis US Corp. | $19.51 | 2023 | Radial 360 |
| Baylis Medical Company INC | $16.21 | 2021 | |
| Shockwave Medical, INC | $13.34 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.00 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.